Join to view full profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673
Dr. Stewart is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. F. Marc Stewart is an oncologist based in Duarte, CA, specializing in hematologic oncology. He completed his medical education at Indiana University School of Medicine, followed by residency in Internal Medicine and fellowships inHematology/Medical Oncology at Indiana University and the University of Virginia Medical Center. Dr. Stewart is currently the Chief Medical Officer at City of Hope’s National Medical Center since 2020 and previously worked as an oncology Chief Medical Officer at Fred Hutchinson Cancer Research Center, Seattle Children's Hospital and UW Medicine. His expertise encompasses conditions focusing on hematologic malignancy and BMT. He has authored several publications, including studies on hematologic malignancies and transplantation outcomes.
Education & Training
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1980 - 1981- Indiana University School of MedicineResidency, Internal Medicine, 1978 - 1980
Bridgeport Hospital/Yale UniversityInternship, Internal Medicine, 1977 - 1978- Indiana University School of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 2020 - 2028
IL State Medical License 2024 - 2026
WA State Medical License 2000 - 2023
CT State Medical License 1994 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Genetic Landscape of Acute Leukemia of Ambiguous Lineage: A Single Cancer Center Experience.Fei Fei, Milhan Telatar, Lisa Chang, Hui Pan, Sunmin Park
The Journal of Molecular Diagnostics. 2026-08-01 - Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT.Diana T Samuels, Brian J Ball, Ni-Chun Tsai, Salman Otoukesh, Shukaib Arslan
Blood Neoplasia. 2026-08-01 - Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment.Tina Nguyen, Tanya Markary, Ni-Chun Tsai, Katrin Tiemann, Sally Mokhtari
Transplantation and Cellular Therapy. 2025-10-01
Grant Support
- Cancer And Leukemia Group BNational Cancer Institute1998–1999
- Alternative Sources Of Hematopoietic RenewalNational Cancer Institute1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
